Abintus Bio
PrivateLast Round
Series B
Aug 15, 2022
Total Funding Raised
$15.65M
Company Overview
Abintus Bio, Inc. is a preclinical stage biotechnology company founded in 2020 and based in San Diego, CA. The company is focused on developing first-in-class, in vivo genetic medicines designed to reprogram a patient's immune cells directly within the body. Utilizing its proprietary Modular Viral Platform (MVP), Abintus Bio's initial products, known as In Vivo CAR-X, aim to create potent and durable immune responses against hematologic malignancies and solid tumors. This approach is intended to serve as an off-the-shelf therapy, potentially overcoming challenges associated with traditional ex vivo CAR technologies and improving treatment access and outcomes for patients. The company has received backing from investors including Takeda Ventures and The Leukemia & Lymphoma Society's Therapy Acceleration Program® (LLS TAP).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abintus Bio Comps
Public and private peers based on sector, stage, and business model.
Abintus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 15, 2022 |
Key People
Founding team and executive leadership
Abintus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skyviews Life Science | Series B |
| Tech Coast Angels | Series B |
| Leukemia & Lymphoma Society | Series B |
| SeedFolio | Series B |
| BioBrit | Series B |
| Takeda Ventures | Series B |
Abintus Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abintus Bio's valuation, stock price, and market status.
